Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
about
Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.Microbiota Is Involved in Post-resection Adaptation in Humans with Short Bowel Syndrome.Endocrine-disrupting chemicals and the regulation of energy balance.Gastrointestinal Complications of Obesity.Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation.Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD.Role of Incretin Axis in Inflammatory Bowel Disease.Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice.Pro-inflammatory cytokines after an episode of acute pancreatitis: associations with fasting gut hormone profile.Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults.Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer.Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons.Does Gastric Surgery (Such as Bariatric Surgery) Impact the Risk of Intestinal Inflammation?Fra-2 Expression in Osteoblasts Regulates Systemic Inflammation and Lung Injury through Osteopontin
P2860
Q30239737-646A5533-AE43-4C17-84E7-6B332A11E43CQ33575682-2160977C-B134-4A08-8433-880BE539FE8FQ39317709-1F1B3E56-7B6E-473C-8F7A-E50395FB4AFBQ40338492-F9B648B6-F4C0-43E5-8712-0CDE4BF7CCDEQ42366248-3BC90AB0-E79B-4A8D-8408-CC6B70209089Q44877422-4A556682-3346-45EF-9476-B59F77443670Q47103249-D6FE4EF8-EC21-4936-8485-EAC081F565D5Q47109985-2F741317-469C-4D15-A474-194D78356C45Q47243992-399C958F-453A-4D2F-B5E5-B16126C50AD0Q47709491-477B7EEF-CDC0-466F-95E3-0A0513B1AE3BQ48509358-73C95048-838E-4D65-9076-BEF382862261Q48553803-1D34D577-BAF0-436D-8859-A2D1828CF409Q52644182-E66E05CF-401F-4583-ABA6-DB5D1B199D95Q55004136-F2A0F1A5-77F0-43C4-A487-4BDF04D44F82Q55220546-E4598D01-56C4-4E1E-A39A-245D5193258DQ58326827-B6BC959A-5C3D-406B-8011-FE1C51A59FEF
P2860
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
@ast
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
@en
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
@nl
type
label
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
@ast
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
@en
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
@nl
prefLabel
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
@ast
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
@en
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
@nl
P2860
P3181
P356
P1476
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
@en
P2093
Tamara Zietek
P2860
P3181
P356
10.3389/FIMMU.2016.00154
P407
P577
2016-01-01T00:00:00Z